FluoSphera
9 employees on LinkedIn · 2 known investors
FluoSphera develops an in vitro drug discovery platform that combines encapsulated multi-tissue organoids into a multi-organ system to mimic human systemic responses and predict clinical drug outcomes before trials. The technology enables high-resolution drug profiling for pharmaceutical and drug discovery research.
Investors · 2
Frequently asked questions
- What does FluoSphera do?
- FluoSphera develops an in vitro drug discovery platform that combines encapsulated multi-tissue organoids into a multi-organ system to mimic human systemic responses and predict clinical drug outcomes before trials. The technology enables high-resolution drug profiling for pharmaceutical and drug discovery research.
- Who are FluoSphera's investors?
- FluoSphera's investors include SICTIC, Soulmates Ventures.